301408 Stock Overview
Anhui Huaren Health Pharmaceutical Co., Ltd. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Anhui Huaren Health Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.51 |
52 Week High | CN¥19.53 |
52 Week Low | CN¥9.30 |
Beta | 0 |
11 Month Change | 6.56% |
3 Month Change | 28.84% |
1 Year Change | -33.07% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -31.11% |
Recent News & Updates
Recent updates
Shareholder Returns
301408 | CN Consumer Retailing | CN Market | |
---|---|---|---|
7D | 1.5% | -0.9% | -0.9% |
1Y | -33.1% | -11.0% | 5.4% |
Return vs Industry: 301408 underperformed the CN Consumer Retailing industry which returned -11% over the past year.
Return vs Market: 301408 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
301408 volatility | |
---|---|
301408 Average Weekly Movement | 9.4% |
Consumer Retailing Industry Average Movement | 7.9% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 301408 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301408's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 6,873 | n/a | www.hrjkjt.com |
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, bruises bones disease, endocrine, heat-clearing, respiratory system, cold, anti-allergic, ophthalmology, antipyretic, analgesic, rheumatism pediatrics, skin, and gynecology, as well as provides vitamins and minerals, detoxifying, and antibacterial and anti-inflammatory products.
Anhui Huaren Health Pharmaceutical Co., Ltd. Fundamentals Summary
301408 fundamental statistics | |
---|---|
Market cap | CN¥5.00b |
Earnings (TTM) | CN¥134.58m |
Revenue (TTM) | CN¥4.39b |
37.2x
P/E Ratio1.1x
P/S RatioIs 301408 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301408 income statement (TTM) | |
---|---|
Revenue | CN¥4.39b |
Cost of Revenue | CN¥3.02b |
Gross Profit | CN¥1.37b |
Other Expenses | CN¥1.24b |
Earnings | CN¥134.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.34 |
Gross Margin | 31.21% |
Net Profit Margin | 3.07% |
Debt/Equity Ratio | 52.8% |
How did 301408 perform over the long term?
See historical performance and comparison